Shay Capital’s Relmada Therapeutics RLMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$67.9K Buy
+18,014
New +$88.4K ﹤0.01% 469
2024
Q4
– Sell
-175,547
Closed -$569K – 408
2024
Q3
$569K Buy
+175,547
New +$569K 0.08% 148

Other funds holding RLMD

Shay Capital's RLMD Position: Q3 2026 in Review

Shay Capital opened a new position in Relmada Therapeutics (RLMD) in Q3 2026: 18,014 shares worth $67.9K. The stake represents ﹤0.01% of the portfolio and ranks #469 among its holdings. This is a return to the name: Shay Capital previously reported a position in RLMD as recently as Q3 2024.

Shay Capital first reported a position in RLMD in Q3 2024 and has held it in 2 quarters since. The position peaked at $569K in Q3 2024. 105 funds tracked by Wall St. Rank hold RLMD as of Q3 2026.

  • Shay Capital held 18,014 shares of Relmada Therapeutics worth $67.9K as of Q3 2026.
  • Relmada Therapeutics was a new Shay Capital position in Q3 2026.
  • Relmada Therapeutics made up ﹤0.01% of Shay Capital's portfolio in Q3 2026, its #469 holding.
  • Shay Capital first reported a position in Relmada Therapeutics in Q3 2024 and has held it in 2 quarters since.
  • Shay Capital's Relmada Therapeutics position peaked at $569K in Q3 2024.
  • 105 funds tracked by Wall St. Rank held Relmada Therapeutics as of Q3 2026.

Based on Shay Capital's 13F filing for Q3 2026, filed 16 Nov 2026.